Collegium Pharmaceutical, Inc., a specialty pharmaceutical company committed to being the leader in responsible pain management, announced that management will participate in the following investor conferences during the month of September
STOUGHTON, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences during the month of September:
H.C. Wainwright 23rd Annual Global Investment Conference
Format: Fireside chat
Date: Monday, September 13, 2021
Time: 7:00 – 7:30 AM Eastern Time
Cantor Virtual Global Healthcare Conference
Format: Virtual presentation
Date: Tuesday, September 28, 2021
Time: 8:00 – 8:30 AM Eastern Time
The presentations will be webcast live and may be accessed from the Investor section of the Company’s website: https://ir.collegiumpharma.com. A replay of the webcasts will be available on the Company’s website for approximately 30 days after the event.
About Collegium Pharmaceutical, Inc.
Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.
Contact:
MacDougall Advisors
collegium@macbiocom.com
